Matches in Wikidata for { <http://www.wikidata.org/entity/Q91849010> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q91849010 description "article scientifique publié en 2020" @default.
- Q91849010 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91849010 description "scientific article published on 13 April 2020" @default.
- Q91849010 description "wetenschappelijk artikel" @default.
- Q91849010 description "наукова стаття, опублікована 13 квітня 2020" @default.
- Q91849010 name "Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer" @default.
- Q91849010 name "Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer" @default.
- Q91849010 type Item @default.
- Q91849010 label "Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer" @default.
- Q91849010 label "Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer" @default.
- Q91849010 prefLabel "Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer" @default.
- Q91849010 prefLabel "Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer" @default.
- Q91849010 P1433 Q91849010-5FC069FD-E725-4E0F-B004-2222D9D9A242 @default.
- Q91849010 P1476 Q91849010-21C2D0FF-9ABA-40B2-95F6-8A3956C2A012 @default.
- Q91849010 P2093 Q91849010-04B8CC6D-BB3D-4E35-9F22-BB07893B108C @default.
- Q91849010 P2093 Q91849010-10EEFF3C-0F9D-4177-94E4-0E21A6F2A22F @default.
- Q91849010 P2093 Q91849010-19633901-ECC6-4291-BB05-220F9385214A @default.
- Q91849010 P2093 Q91849010-33F89BF1-0F52-4458-9C77-6BA033C034A6 @default.
- Q91849010 P2093 Q91849010-4603A3DD-DF02-4F72-87B0-57ED4839CA5F @default.
- Q91849010 P2093 Q91849010-589F3D3A-5F81-4FC9-AECB-F51E16C5B9BF @default.
- Q91849010 P2093 Q91849010-8B1EC37D-5FDA-403B-9107-E45BD4C47AEF @default.
- Q91849010 P2093 Q91849010-CEBEA1C9-0989-4160-8CBE-7EC1788D59B9 @default.
- Q91849010 P2093 Q91849010-D7BFBCB6-DFB7-4397-B827-25EE5540CA70 @default.
- Q91849010 P2093 Q91849010-E1E383B3-E691-4566-A1FF-5E85956EE0F4 @default.
- Q91849010 P2093 Q91849010-F9A850F1-974F-4B74-A4DF-DD8109FD0FD9 @default.
- Q91849010 P31 Q91849010-DD1F5EDB-A2CC-4427-9201-6D1ED34AFEFB @default.
- Q91849010 P356 Q91849010-C3EFBF11-7E51-4B73-9E53-4C227AB82757 @default.
- Q91849010 P50 Q91849010-A244DD31-ECC5-4BC3-9A4F-E0D870AA8540 @default.
- Q91849010 P50 Q91849010-AF3DEA31-A815-4D51-B9D9-8DAEF3A21CEB @default.
- Q91849010 P577 Q91849010-05660085-18E3-4382-BC1D-7BB283C6C57E @default.
- Q91849010 P698 Q91849010-16AE35A4-D736-49E3-828C-B83CFFB6EB83 @default.
- Q91849010 P932 Q91849010-A87CDFB5-CD67-4AC4-86C0-9A7C40077A50 @default.
- Q91849010 P356 1759-7714.13426 @default.
- Q91849010 P698 32281272 @default.
- Q91849010 P1433 Q26842004 @default.
- Q91849010 P1476 "Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer" @default.
- Q91849010 P2093 "Allen Chung-Cheng Huang" @default.
- Q91849010 P2093 "Cheng-Ta Yang" @default.
- Q91849010 P2093 "Chia-Hsun Chu" @default.
- Q91849010 P2093 "Chien-Ying Liu" @default.
- Q91849010 P2093 "Chih-Liang Wang" @default.
- Q91849010 P2093 "Chin-Chou Wang" @default.
- Q91849010 P2093 "Fu-Tsai Chung" @default.
- Q91849010 P2093 "Ho-Wen Ko" @default.
- Q91849010 P2093 "Tzu-Hsuan Chiu" @default.
- Q91849010 P2093 "Wen-Chen Chang" @default.
- Q91849010 P2093 "Yi-Ke Guo" @default.
- Q91849010 P31 Q13442814 @default.
- Q91849010 P356 "10.1111/1759-7714.13426" @default.
- Q91849010 P50 Q88164008 @default.
- Q91849010 P50 Q90714634 @default.
- Q91849010 P577 "2020-04-13T00:00:00Z" @default.
- Q91849010 P698 "32281272" @default.
- Q91849010 P932 "7262925" @default.